In addition, experiments showed that lncRNA H19 expression in the postoperative serum sample was significantly lower than preoperative levels (P|0.000 6), suggesting that H19 could be used for pre-testing in addition to being a breast cancer marker. The gene discussed is H19; the disease is breast carcinoma.